Cite
Substance Use Treatment Utilization Among Women With and Without Human Immunodeficiency Virus.
MLA
Fujita, Ayako W., et al. “Substance Use Treatment Utilization Among Women With and Without Human Immunodeficiency Virus.” Open Forum Infectious Diseases, vol. 10, no. 1, Jan. 2023, pp. 1–13. EBSCOhost, https://doi.org/10.1093/ofid/ofac684.
APA
Fujita, A. W., Ramakrishnan, A., Mehta, C. C., Yusuf, O. B., Wilson, T., Shoptaw, S., Carrico, A. W., Adimora, A. A., Eaton, E., Cohen, M. H., Cohen, J., Adedimeji, A., Plankey, M., Jones, D., Chandran, A., Colasanti, J. A., & Sheth, A. N. (2023). Substance Use Treatment Utilization Among Women With and Without Human Immunodeficiency Virus. Open Forum Infectious Diseases, 10(1), 1–13. https://doi.org/10.1093/ofid/ofac684
Chicago
Fujita, Ayako W, Aditi Ramakrishnan, C Christina Mehta, Oyindamola B Yusuf, Tracey Wilson, Steven Shoptaw, Adam W Carrico, et al. 2023. “Substance Use Treatment Utilization Among Women With and Without Human Immunodeficiency Virus.” Open Forum Infectious Diseases 10 (1): 1–13. doi:10.1093/ofid/ofac684.